Trial Profile
The effects of telbivudine treatment on circulating Tregs and its significance in hepatitis B patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 12 Mar 2012 New trial record